V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
Biopharma & Life Sciences

Avantor Executive Compensation (FY25)

AVTR · Radnor, PA · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): May 12, 2026
349 figures on this page: 343 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
Emmanuel Ligner was paid $5,895,624 in total compensation as Director, President and Chief Executive Officer for fiscal 2025, and the disclosed chief executive pay ratio for fiscal 2025 is 148:1, against median employee compensation of $47,791. Separately, the disclosed peer group names Agilent Technologies, Inc., Baxter International, Inc., Bio-Rad Laboratories, Inc., Biogen Inc. and Bruker Corporation, among others, and the company reported 6 named executive officers for fiscal 2025. Shareholders supported the say-on-pay proposal with 96.9% of votes cast including abstentions in favor at the meeting held May 7, 2026 for fiscal 2025.
Chief executive, fiscal 2025
◇
Emmanuel Ligner
Median of the other named officers
$5,987,816
5 officers, excluding the chief executive
Latest say-on-pay support
=
May 7, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Michael Stubblefield → Emmanuel Ligner
Say-on-pay support: 86.5% → 96.9% (10.4 points higher)
CEO pay ratio: 303:1 → 148:1 (51.2% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Avantor's chief executive and what were they paid?
Emmanuel Ligner was paid $5,895,624 in total compensation as Director, President and Chief Executive Officer for fiscal 2025.
What was Avantor's say-on-pay result?
Shareholders supported the say-on-pay proposal with 96.9% of votes cast including abstentions in favor at the meeting held May 7, 2026 for fiscal 2025.
Which companies are in Avantor's peer group?
The disclosed peer group names Agilent Technologies, Inc., Baxter International, Inc., Bio-Rad Laboratories, Inc., Biogen Inc. and Bruker Corporation, among others.
What is Avantor's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 148:1, against median employee compensation of $47,791.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Stubblefield
President and Chief Executive Officer
◇—◇◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Stubblefield
President and Chief Executive Officer
◇—◇◇◇◇◇◇
R. Brent Jones
Executive Vice President and Chief Financial Officer
◇◇◇◇◇—◇◇
James Bramwell
Executive Vice President and Chief Commercial Officer
◇—◇◇◇◇◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Stubblefield
President and Chief Executive Officer
◇—◇◇◇—◇◇
R. Brent Jones
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Benoit Gourdier
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Randy Stone
Former Executive Vice President, Laboratory Solutions
Departed during or after this year
◇—◇◇◇—◇◇
James Bramwell
Executive Vice President and Chief Commercial Officer
◇—◇◇◇—◇◇
Claudius Sokenu
Executive Vice President, General Counsel and Corporate Secretary
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Stubblefield
Former Chief Executive Officer
Departed during or after this year
◇—◇◇◇—◇◇
R. Brent Jones
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Corey Walker
President Laboratory Solutions
◇—◇◇◇—◇◇
Emmanuel Ligner
Director, President and Chief Executive Officer
◇—◇◇◇—◇◇
Benoit Gourdier
Executive Vice President Bioscience Production
◇—◇◇◇—◇◇
Claudius Sokenu
Executive Vice President, Chief Legal and Compliance Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Benoit GourdierRSU◇——◇——◇
Benoit GourdierOPTION◇——◇—◇◇
Benoit GourdierPSU◇◇◇—◇—◇
Benoit GourdierRSU◇——◇——◇
Claudius SokenuRSU◇——◇——◇
Claudius SokenuPSU◇◇◇—◇—◇
Claudius SokenuRSU◇——◇——◇
Claudius SokenuOPTION◇——◇—◇◇
Corey WalkerPSU◇◇◇—◇—◇
Corey WalkerRSU◇——◇——◇
Corey WalkerOPTION◇——◇—◇◇
Corey WalkerRSU◇——◇——◇
Emmanuel LignerOPTION◇——◇—◇◇
Emmanuel LignerRSU◇——◇——◇
Michael StubblefieldRSU◇——◇——◇
Michael StubblefieldPSU◇◇◇—◇—◇
Michael StubblefieldOPTION◇——◇—◇◇
R. Brent JonesRSU◇——◇——◇
R. Brent JonesRSU◇——◇——◇
R. Brent JonesOPTION◇——◇—◇◇
R. Brent JonesPSU◇◇◇—◇—◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Benoit GourdierPSU◇◇——
PSU◇◇——
Option◇—◇10/02/33
Option◇—◇02/23/34
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇02/20/35
Michael StubblefieldOption◇—◇02/23/34
Option◇—◇02/20/30
Option◇—◇09/30/26
Option◇—◇12/13/27
Option◇—◇02/23/32
Option◇—◇02/20/35
PSU◇◇——
Option◇—◇02/25/31
PSU◇◇——
Option◇—◇02/24/33
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
Emmanuel LignerPSU◇◇——
Option◇—◇18/08/2035
Corey WalkerPSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇02/20/35
Option◇—◇06/21/34
PSU◇◇——
Claudius SokenuOption◇—◇02/20/35
PSU◇◇——
PSU◇◇——
Option◇—◇02/23/34
PSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇07/24/33
PSU◇◇——
PSU◇◇——
R. JonesOption◇—◇08/07/33
Option◇—◇02/23/34
Option◇—◇02/20/35
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jonathan Peacock
Board chair
◇◇————◇
Dame Louise Makin
◇◇———◇◇
Joseph Massaro
◇◇————◇
Gregory Summe
◇◇————◇
Michael Severino
◇◇————◇
Mala Murthy
◇◇————◇
Juan Andres
◇◇————◇
Lan Kang
◇◇————◇
John Carethers
◇◇————◇
Gregory T. Lucier
◇◇————◇
Sanjeev Mehra
◇◇————◇
Emmanuel Ligner and Simon Dingemans served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee member◇
Compensation committee member◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Agilent Technologies, Inc. A
  • Baxter International, Inc. BAX
  • Bio-Rad Laboratories, Inc. BIO
  • Biogen Inc. BIIB
  • Bruker Corporation BRKR
  • Charles River Laboratories International, Inc. CRL
  • Edwards Lifesciences EW
  • Hologic, Inc. HOLX
  • Illumina, Inc. ILMN
  • IQVIA Holdings Inc. IQV
  • Laboratory Corp. of America symbol not shown
  • Mettler-Toledo International Inc MTD
  • Quest Diagnostics Inc. DGX
  • Revvity, Inc. RVTY
  • Waters Corporation WAT
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 7, 2026=◇◇◇
2024May 8, 2025=◇◇◇
2023May 9, 2024=◇◇◇
2022May 11, 2023=◇◇◇
2021May 12, 2022=◇◇◇
2019May 7, 2020=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Avantor files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Avantor disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Avantor sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Avantor's disclosed peer group is defensible, who names Avantor back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
349 figures on this page: 343 cited to the filing that reported them, 6 calculated from figures it prints.
343 cited to the filing
6 calculated from the filing

Documents cited

  1. 0001628280-26-034146
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001628280-26-021572
    CEO Pay Ratio · Director Compensation · Director Fees · ELEMENTS OF COMPENSATION & · and 3 more sections
  3. 0001722482-25-000143
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000950170-25-046778
    Summary Compensation Table
  5. 0001722482-24-000109
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001193125-24-082080
    SUMMARY COMPENSATION TABLE
  7. 0001722482-23-000103
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001193125-23-088080
    Summary Compensation Table
  9. 0001722482-22-000121
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001722482-20-000096
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Avantor executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/AVTR (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Avantor and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Biopharma & Life Sciences rankings

Chief executive pay — Biopharma & Life SciencesCEO pay ratio — Biopharma & Life SciencesSay-on-pay support — Biopharma & Life Sciences

Peers Avantor discloses

The companies named in AVTR's own disclosed peer group.

Agilent Technologies, Inc.Baxter International, Inc.Bio-Rad Laboratories, Inc.Biogen Inc.Bruker CorporationCharles River Laboratories International, Inc.Edwards LifesciencesHologic, Inc.Illumina, Inc.IQVIA Holdings Inc.Mettler-Toledo International IncRevvity, Inc.Waters CorporationZimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy